Title |
Developing science gateways for drug discovery in a grid environment
|
---|---|
Published in |
SpringerPlus, August 2016
|
DOI | 10.1186/s40064-016-2914-x |
Pubmed ID | |
Authors |
Horacio Pérez-Sánchez, Horacio Pérez-Sánchez, Vahid Rezaei, Vitaliy Mezhuyev, Duhu Man, Jorge Peña-García, Helena den-Haan, Sandra Gesing |
Abstract |
Methods for in silico screening of large databases of molecules increasingly complement and replace experimental techniques to discover novel compounds to combat diseases. As these techniques become more complex and computationally costly we are faced with an increasing problem to provide the research community of life sciences with a convenient tool for high-throughput virtual screening on distributed computing resources. To this end, we recently integrated the biophysics-based drug-screening program FlexScreen into a service, applicable for large-scale parallel screening and reusable in the context of scientific workflows. Our implementation is based on Pipeline Pilot and Simple Object Access Protocol and provides an easy-to-use graphical user interface to construct complex workflows, which can be executed on distributed computing resources, thus accelerating the throughput by several orders of magnitude. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 21 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Bachelor | 4 | 19% |
Professor | 2 | 10% |
Researcher | 2 | 10% |
Student > Ph. D. Student | 2 | 10% |
Student > Doctoral Student | 1 | 5% |
Other | 4 | 19% |
Unknown | 6 | 29% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 3 | 14% |
Computer Science | 3 | 14% |
Engineering | 2 | 10% |
Chemistry | 2 | 10% |
Biochemistry, Genetics and Molecular Biology | 2 | 10% |
Other | 3 | 14% |
Unknown | 6 | 29% |